Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Main Authors: | Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, Yolanda Aguilera, Lucía Llanos, Juan R. Tejedo, Francisco J. Bedoya, Verónica Juan, Antonio De la Cuesta, Rafael Ruiz-Salmerón, Enrique Andreu, Lukas Grochowicz, Felipe Prósper, Fermín Sánchez-Guijo, Francisco S. Lozano, Manuel Miralles, Lourdes Del Río-Solá, Gregorio Castellanos, José M. Moraleda, Robert Sackstein, Mariano García-Arranz, Damián García-Olmo, Franz Martín, Abdelkrim Hmadcha, Bernat Soria, the Collaborative Working Group “Noma Project Team” |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.02029/full |
Similar Items
-
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
by: Bárbara Soria-Juan, et al.
Published: (2019-06-01) -
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
by: Abdelkrim Hmadcha, et al.
Published: (2020-02-01) -
Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells
by: Natalia Escacena, et al.
Published: (2015-01-01) -
Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis.
by: José A G Pertusa, et al.
Published: (2017-01-01) -
Transient Downregulation of Nanog and Oct4 Induced by DETA/NO Exposure in Mouse Embryonic Stem Cells Leads to Mesodermal/Endodermal Lineage Differentiation
by: Sergio Mora-Castilla, et al.
Published: (2014-01-01)